Sittner & Nelson’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$96.4K Hold
2,000
0.04% 229
2025
Q4
$95.7K Buy
2,000
+1,000
+100% +$49.6K 0.03% 217
2025
Q3
$47.2K Buy
+1,000
New +$48.3K 0.02% 260
2024
Q4
Sell
-2,000
Closed -$115K 503
2024
Q3
$115K Buy
2,000
+1,700
+567% +$91.8K 0.05% 168
2024
Q2
$14.6K Hold
300
0.01% 318
2024
Q1
$14.6K Hold
300
0.01% 313
2023
Q4
$14.9K Buy
+300
New +$14.7K 0.01% 312
2023
Q1
Sell
-200
Closed -$9.69K 495
2022
Q4
$9.69K Hold
200
0.01% 347
2022
Q3
$8K Hold
200
0.01% 356
2022
Q2
$10K Hold
200
0.01% 364
2022
Q1
$10K Hold
200
0.01% 345
2021
Q4
$10K Hold
200
0.01% 342
2021
Q3
$10K Hold
200
0.01% 324
2021
Q2
$11K Hold
200
0.01% 298
2021
Q1
$10K Hold
200
0.01% 298
2020
Q4
$10K Buy
+200
New +$9.86K 0.01% 288

Other funds holding SNY

Sittner & Nelson's SNY Position: Q1 2026 in Review

Sittner & Nelson held its Sanofi (SNY) position steady in Q1 2026 at 2,000 shares worth $96.4K. The position accounts for 0.04% of the portfolio, ranked #229.

Sittner & Nelson first reported a position in SNY in Q4 2020 and has held it in 16 quarters since. The position peaked at $115K in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Sittner & Nelson held 2,000 shares of Sanofi worth $96.4K as of Q1 2026.
  • Sittner & Nelson left its Sanofi share count unchanged in Q1 2026.
  • Sanofi made up 0.04% of Sittner & Nelson's portfolio in Q1 2026, its #229 holding.
  • Sittner & Nelson first reported a position in Sanofi in Q4 2020 and has held it in 16 quarters since.
  • Sittner & Nelson's Sanofi position peaked at $115K in Q3 2024.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.